Share on StockTwits
 

Amarin Co. plc (NASDAQ:AMRN) issued its quarterly earnings data on Thursday. The company reported ($0.26) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.23) by $0.03, American Banking News reports. The company had revenue of $10.10 million for the quarter, compared to the consensus estimate of $11.17 million.

Shares of Amarin Co. plc (NASDAQ:AMRN) traded down 0.56% on Thursday, hitting $1.78. The stock had a trading volume of 4,597,970 shares. Amarin Co. plc has a 52 week low of $1.36 and a 52 week high of $8.77. The stock’s 50-day moving average is $1.88 and its 200-day moving average is $3.39. The company’s market cap is $307.3 million.

AMRN has been the subject of a number of recent research reports. Analysts at MKM Partners cut their price target on shares of Amarin Co. plc from $2.50 to $1.75 in a research note on Monday. They now have a “neutral” rating on the stock. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $5.11.

Amarin Corporation plc (NASDAQ:AMRN) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.